Recent Comments

Comment RSS

Chromosome News and Research RSS Feed - Chromosome News and Research

In the nucleus of each cell, the DNA molecule is packaged into thread-like structures called chromosomes. Each chromosome is made up of DNA tightly coiled many times around proteins called histones that support its structure.

Chromosomes are not visible in the cell’s nucleus—not even under a microscope—when the cell is not dividing. However, the DNA that makes up chromosomes becomes more tightly packed during cell division and is then visible under a microscope. Most of what researchers know about chromosomes was learned by observing chromosomes during cell division.

Each chromosome has a constriction point called the centromere, which divides the chromosome into two sections, or “arms.” The short arm of the chromosome is labeled the “p arm.” The long arm of the chromosome is labeled the “q arm.” The location of the centromere on each chromosome gives the chromosome its characteristic shape, and can be used to help describe the location of specific genes.

Microarray analysis can identify chromosome abnormalities in children with Pitt-Hopkins syndrome

19. November 2009 06:26
Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities, recently showed that microarray analysis can identify small DNA alterations in individuals with Pitt-Hopkins syndrome, a rare and poorly characterized genetic disorder. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , ,

Possible new approach to slow the progression of cognitive decline in Down's syndrome

19. November 2009 04:41
A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome. [More]

Asuragen enters into an exclusive agreement with Life Technologies

18. November 2009 04:13
Asuragen, Inc. announced today that it has entered into an exclusive agreement with Life Technologies Corporation to develop and distribute worldwide an in-vitro diagnostic test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). [More]

Posted in: Business / Finance | Device / Technology News

Tags: , , , , , , ,

Cytoskeleton plays a critical role to bring chromosome pairs together: Study

16. November 2009 06:22
Meiosis - the pairing and recombination of chromosomes, followed by segregation of half to each egg or sperm cell - is a major crossroads in all organisms reproducing sexually. Yet, how the cell precisely choreographs these chromosomal interactions is a long-standing question. [More]

Posted in: Medical Science News

Tags: , , , , , ,

Research team identifies five new gene regions that raise the risk of childhood-onset IBD

16. November 2009 02:07
In the largest, most comprehensive genetic analysis of childhood-onset inflammatory bowel disease (IBD), an international research team has identified five new gene regions, including one involved in a biological pathway that helps drive the painful inflammation of the digestive tract that characterizes the disease. [More]

DSALA "15th Annual Buddy Walk" to raise awareness about Down syndrome

13. November 2009 07:11
15th Annual Buddy Walk and Festival for the Down Syndrome Association of Los Angeles. Buddy Walks are a national event of the National Down Syndrome Society held across the United States each fall to bring awareness and support to individuals born with Down syndrome and their families. [More]

Posted in: Medical Condition News

Tags: ,

Co-founders of Signature Genomics recognized with Inland Northwest Catalyst Award

12. November 2009 04:31
Signature Genomics, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, today announced company co-founders Dr. Lisa G. Shaffer, Ph.D., and Dr. Bassem A. Bejjani, M.D. have received the 2009 Inland Northwest Catalyst Award for Innovators of the Year. [More]

Posted in: Medical Science News

Tags: , ,

U.S. Patent and Trademark Office awards new patent for Ryogen

12. November 2009 01:52
Ryogen LLC, a genomic start-up company, has been awarded a new patent titled “Isolated Genomic Polynucleotide Fragments from Chromosome 7”. [More]

Posted in: Medical Patent News

Tags: , , , , ,

Activating TAp63 protein, a viable anti-cancer strategy

10. November 2009 03:17
Oncologists have had their hands tied because more than half of all human cancers have mutations that disable a protein called p53. As a critical anti-cancer watchdog, p53 masterminds several cancer-fighting operations within cells. When cells lose p53, tumors grow aggressively and often cannot be treated. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , , , , ,

CytRx reports financial results for the three months and nine months ended September 30, 2009

9. November 2009 09:17
CytRx Corporation, a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009. [More]

Chinese SFDA approves China Medical Technologies' Leukemia BCR/ABL fusion gene detection FISH Probe

9. November 2009 07:56
China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH Probe") from the State Food and Drug Administration of China (the "SFDA"). [More]

Cellular mechanisms that may impact immune functions in the elderly discovered

9. November 2009 03:15
Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla. [More]

Researchers find compound that reverses type 1 myotonic dystrophy

7. November 2009 00:42
A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York. [More]

Autism Consortium holds its fourth annual symposium to update on autism

6. November 2009 02:43
The Autism Consortium, an innovative collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), held its fourth annual symposium on October 28th, 2009, at Harvard Medical School in Boston. [More]

Seaside Therapeutics commences STX107 Phase 1 clinical trial for Fragile X Syndrome

3. November 2009 05:18
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.